Skip to main content
Clinical and Translational Medicine logoLink to Clinical and Translational Medicine
editorial
. 2025 Dec 26;16(1):e70558. doi: 10.1002/ctm2.70558

Expotype–phenotype resilience and multimodal aging clocks

Hernan Hernandez 1, Agustin Ibanez 1,2,3,4,
PMCID: PMC12743139  PMID: 41454487

1. MULTIMODAL RESILIENCE IN AGING

Aging trajectories vary widely across individuals, even under comparable biological and environmental pressures, yet most biomedical frameworks prioritize vulnerability over protection. This perspective proposes a shift towards identifying resilient expotype–phenotypes, defined by combinations of exposures and individual adaptive responses that support unexpectedly healthy aging. We propose multimodal aging clocks (focusing on delayed agers) to address resilience and its phenotypic and expotype contributions. Building on recent evidence from global exposome analyses 1 , 2 , 3 , 4 , multimodal aging clocks 1 , 5 , 6 , 7 , 8 and neuroecological frameworks 2 , 9 , we argue that resilience offers an essential dimension for precision brain health.

The exposome 1 , 10 captures the totality of physical, social and sociopolitical exposures across the lifespan, exerting marked influences on biological, systemic and cognitive health. This multidimensional construct provides a foundation for defining expotypes 11 , the characteristic combinations of exposures that shape individual risk or protection 12 . Aging clocks (epigenetic clocks, proteomic or multi‐omic clocks, brain clocks and biobehavioural clocks) quantify biological aging relative to chronological time, enabling direct assessment of how exposures modulate aging trajectories. These tools reveal that diverse exposures, from pollution and temperature peaks to structural inequalities and political instability, accelerate biological aging, 1 , 2 , 6 whereas enriching environments, cognitive stimulation and social cohesion may delay it. Together, they provide a framework for evaluating how cumulative exposures influence aging across datasets, populations and biological systems 12 , 13 . Thus, the exposome and aging clocks may jointly enable a more mechanistic assessments of how protective and adverse exposures shape biological aging across systems.

Our recent Nature Medicine study illustrates how biobehavioural age gaps (BBAGs) – the discrepancy between predicted age from protective/risk factors and chronological age – capture delayed or accelerated aging across 40 countries 1 . BBAGs were estimated using a Gradient Boosting Regressor with 10‐fold cross‐validation to predict age from biobehavioural factors (risk and protective) in >160 000 participants. The age gap was computed as predicted minus chronological age, with negative values indicating delayed and positive values indicating accelerated aging. To correct regression‐to‐the‐mean, gaps were residualized against chronological age using coefficients from the training set and applied to the test set. Delayed BBAGs were linked to favourable exposomes: cleaner air, inclusive migration contexts, structural and gender equality, and democratic stability. These findings illustrate a neurosyndemic, neuroecological processes, where environmental, behavioural and political stressors converge to shape vulnerability or resilience 2 , 13 . They also demonstrate the feasibility of connecting macrostructural features, such as governance, income distribution and collective stress, to individual‐level metrics of aging 13 , 14 , 15 . Integrating exposome dimensions with individual clocks therefore allows the tracing of multiple pathways through which global conditions embed into biological trajectories 16 .

2. CHANGING THE FOCUS FROM VULNERABILITY TO RESILIENCE WITH MULTI‐AGING CLOCKS

Most exposome and aging‐clock studies focus on accelerated aging, disease risk and vulnerability. Yet across populations (particularly those enduring adversity), some individuals exhibit unexpectedly delayed aging or preserved function. Such phenotypes cannot be explained by individual risk factors alone; they point to resilience mechanisms capable of counteracting adverse exposomal conditions. These individuals reveal protective expotypes: interactions of exposures, behaviours and biological processes that sustain healthy trajectories beyond what risk‐based models predict. Understanding these high‐resilient individuals is critical for precision medicine. They provide evidence about protective mechanisms, context‐specific adaptations, individual heterogeneity and compensatory biological dynamics that remain invisible when scientific inquiry centres solely on vulnerability.

Resilience is inherently multimodal, involving biological, psychological, cognitive, social and environmental domains. Recent work 17 shows that genetic factors, epigenetic regulation, inflammation and metabolic flexibility interact with cognitive reserve, emotional regulation, coping strategies, community bonds and environmental factors to influence brain aging. Physical and social environments, including nutritional stability, pollution, green spaces, governance quality and neighbourhood cohesion, may further modulate these interactions. For example, favourable omic signatures, such as reduced inflammatory burden, may buffer against pollution‐related risks; psychological resilience may mitigate socioeconomic stress; and strong social networks may support metabolic and cognitive stability in environments of chronic adversity. Resilience is not a single trait but a synergetic architecture 17 , integrating multiple processes that collectively preserve healthy aging in challenging contexts.

Multimodal aging clocks offer a powerful means to quantify resilience by identifying delayed aging relative to expected trajectories. Epigenetic clocks capture reduced biological wear; BBAGs signal favourable biobehavioural patterns; and brain clocks reveal structural or functional maintenance. Individuals with extreme delayed clocks represent maximal resilience phenotypes, while those showing moderate delays despite multiple risk exposures reveal compensatory protection. Modelling these patterns within synergetic 12 and syndemic 13 frameworks can disentangle how protective factors interact, rather than treating resilience as a unidimensional construct. Moreover, digital twins 8 and biophysical computational models 12 can generate synthetic scenarios to test how combinations of protective exposures (diet, exercise, education, community engagement, environmental quality) interact with omic and brain dynamics. These simulations can support individualized predictions and scalable interventions that address both person‐level and context‐level variability. In brief, delayed multimodal aging clocks can quantify resilience, enabling mechanistic and individualized analysis of how protective factors buffer aging.

Reframing the exposome from a burden‐centred to a resilience‐centred concept offers multiple benefits. Firstly, it may help to explain why some individuals sustain exceptional health despite adversity and may allow identifying therapeutic pathways underlying these protective adaptations. Secondly, genetic 18 , biological 19 , lifestyle 5 , 9 and psychological 20 protection may reveal resilience as a pluricausal phenomenon rather than a single‐level trait. 17 Thirdly, high‐resilient individuals help refine precision brain health models: their trajectories provide boundary cases that improve predictions, optimize risk stratification and support individualized interventions across heterogeneous settings. This shift may expand aging research beyond deficit accumulation, emphasizing adaptive processes that may be leveraged to design interventions targeting protection rather than merely reducing risk.

3. CONCLUSIONS: A NEW RESEARCH AGENDA

A future research programme (Figure 1) is needed to systematically identify resilience underlaying complex expotypes and phenotypes: multivariate patterns of exposures, biological states, and behaviours that jointly support delayed aging 12 , 13 . Moving beyond isolated predictors, this approach requires integrating multimodal clocks, exposome metrics and resilience indicators into synergetic models 12 , 13 capable of detecting how positive environments interact with individual conditions to shape advantageous trajectories. These approaches must also track how protective exposures compensate for specific vulnerabilities (i.e. metabolic risk, educational disadvantage, pollution or sociopolitical instability) and how these interactions differ across contexts. Such precision will allow interventions to move from universal prescriptions towards context‐sensitive combinations tailored to local conditions and individual profiles. Studying protective expotypes together with phenotypes will inform strategies that promote healthy aging by enhancing resilience through synergistic biological, psychological and environmental pathways.

FIGURE 1.

FIGURE 1

Expotype–phenotype contributions to resilience via multimodal aging clocks. The figure illustrates how two major domains of the expotype (social and physical exposome) and two phenotypes (psychological trails and lifestyle factors) may co‐contribute to resilience processes that shape delayed biological aging. Each domain encompasses exposures: the expotype involves compound factors spanning green areas, air quality, temperature, drought severity, precipitation patterns, soil and water quality, climate‐related disasters, structural and gender equality, unemployment rate, GDP, rule of law, political representation, participation rights and drinking‐water access, while the phenotype includes individual traits such as mental or neurological conditions, demographics, as well as lifestyle factors such as physical activity, weight problems, smoking status, alcohol consumption, sleep quality and social engagement. Together, these configurate internal and external influences acting on an individual's resilience. Converging arrows highlight how these domains collectively modulate resilience, conceptualized as the capacity to maintain or regain function despite adversity. Resilience, in turn, can be measured by multimodal aging clocks, including epi/genetic/omic clocks, biobehavioural age gaps (BBAGs), and brain structural/functional clocks. These clocks quantify delayed or accelerated aging and serve as mechanistic markers of how protective or adverse expotypes shape aging trajectories.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflicts of interest.

ACKNOWLEDGEMENTS

HH is supported by Davos Alzheimer's Collaborative. AI is supported by the Multi‐Partner Consortium to Expand Dementia Research in Latin America (ReDLat), supported by the Fogarty International Center (FIC), the National Institutes of Health, the National Institute on Aging (R01 AG057234, R01 AG075775, R01 AG21051, R01 AG083799, CARDS‐NIH 75N95022C00031), the Alzheimer's Association (SG‐20‐725707), the Rainwater Charitable Foundation – The Bluefield Project to Cure FTD, and the Global Brain Health Institute. AI is also supported by ANID/FONDECYT Regular (1250091, 1210176, 1220995) and ANID/FONDAP/15150012. The contents of this publication are solely the author's responsibility and do not represent the official views of these institutions.

Hernandez H, Ibanez A. Expotype–phenotype resilience and multimodal aging clocks. Clin Transl Med. 2026;16:e70558. 10.1002/ctm2.70558

References

  • 1. Hernandez H, Santamaria‐Garcia H, Moguilner S, et al. The exposome of healthy and accelerated aging across 40 countries. Nat Med. 2025;31(9):3089–3100. 10.1038/s41591-025-03808-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Ibanez A, Melloni L, Swieboda P, et al. Neuroecological links of the exposome and One Health. Neuron. 2024;112(12):1905‐1910. 10.1016/j.neuron.2024.04.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Migeot J, Pina‐Escudero SD, Hernandez H, et al. Social exposome and brain health outcomes of dementia across Latin America. Nat Commun. 2025;16(1):8196. 10.1038/s41467-025-63277-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Legaz A, Altschuler F, Gonzalez‐Gomez R, et al. Structural inequality linked to brain volume and network dynamics in aging and dementia across the Americas. Nat Aging. 2024;5(2):259‐274. 10.1038/s43587-024-00781-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Coronel‐Oliveros C, Migeot J, Lehue F, et al. Creative experiences and brain clocks. Nat Commun. 2025;16(1):8336. 10.1038/s41467-025-64173-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Moguilner S, Baez S, Hernandez H, et al. Brain clocks capture diversity and disparities in aging and dementia across geographically diverse populations. Nat Med. 2024;30(12):3646–3657. 10.1038/s41591-024-03209-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Coronel‐Oliveros C, Moguilner S, Hernandez H, et al. Diversity‐sensitive brain clocks linked to biophysical mechanisms in aging and dementia. Nat Ment Health. 2025;3:1214–1229. 10.1038/s44220-025-00502-7 [DOI] [Google Scholar]
  • 8. Wen J. Towards a multi‐organ, multi‐omics medical digital twin. Nat Biomed Eng. 2025;9(9):1386‐1389. 10.1038/s41551-025-01474-w [DOI] [PubMed] [Google Scholar]
  • 9. Amoruso L, Hernandez H, Santamaria‐Garcia H, et al. Multilingualism protects against accelerated aging in cross‐sectional and longitudinal analyses of 27 European countries. Nat Aging. 2025;5(11):2340‐2354. 10.1038/s43587-025-01000-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Miller GW, Consortium BE. Integrating exposomics into biomedicine. Science. 2025;388(6745):356‐358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Mahdipour M, Maleki Balajoo S, Raimondo F, et al. What predicts individual brain health?: a machine learning study spanning the exposome. 2025. 10.21203/rs.3.rs-6410523/v1 [DOI]
  • 12. Ibáñez A, Duran‐Aniotz C, Migeot J, et al. Computational whole‐body‐exposome models for global precision brain health. Nat Commun. 2025;16:11078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Ibanez A, Kringelbach ML, Deco G. A synergetic turn in cognitive neuroscience of brain diseases. Trends Cogn Sci. 2024:28(4):319‐338. 10.1016/j.tics.2023.12.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Nowogrodzki J. Why Do Ageing Rates Vary by Country? Massive Study Says Politics Play a Part. Nature Publishing Group; 2025. [DOI] [PubMed] [Google Scholar]
  • 15. Time for the exposome to shape policy. Nat Med. 2025;31(9):2823‐2823. 10.1038/s41591-025-03990-3 [DOI] [PubMed] [Google Scholar]
  • 16. Ibanez A. The mind's golden cage and cognition in the wild. Trends Cogn Sci. 2022;26(12):1031‐1034. 10.1016/j.tics.2022.07.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Udeh‐Momoh CT, Migeot J, Blackmon K, et al. Resilience and brain health in global populations. Nat Med. 2025;31(8):2518‐2531. 10.1038/s41591-025-03846-w [DOI] [PubMed] [Google Scholar]
  • 18. Arboleda‐Velasquez JF, Lopera F, O'Hare M, et al. Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019;25(11):1680‐1683. 10.1038/s41591-019-0611-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Mehta RI, Schneider JA. What is ‘Alzheimer's disease’? The neuropathological heterogeneity of clinically defined Alzheimer's dementia. Curr Opin Neurol. 2021;34(2):237‐245. 10.1097/wco.0000000000000912 [DOI] [PubMed] [Google Scholar]
  • 20. Abellaneda‐Pérez K, Cattaneo G, Cabello‐Toscano M, et al. Purpose in life promotes resilience to age‐related brain burden in middle‐aged adults. Alzheimers Res Ther. 2023;15(1):49. 10.1186/s13195-023-01198-6 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Translational Medicine are provided here courtesy of John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics

RESOURCES